Hyperglycemia Associated with Mirtazapine: A Case Report.
- Author:
Young Jae HONG
1
;
Ji Do PARK
;
Jeong Gee KIM
Author Information
1. Department of Neuropsychiatry, Maryknoll Hospital, Pusan.
- Publication Type:Case Report
- Keywords:
Mirtazapine;
Hyperglycemia;
Diabetes mellitus
- MeSH:
Autoreceptors;
Diabetes Mellitus;
Dizziness;
Female;
Glucose;
Humans;
Hyperglycemia*;
Middle Aged;
Norepinephrine;
Serotonin;
Weight Gain
- From:Journal of Korean Neuropsychiatric Association
2001;40(1):151-156
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Mirtazapine-a newly developed drug with reduce adverse effects and toxicity of original antidepre-ssants-has been known to have antidepressant effect by enhancing the transmission of norepinephrine and serotonin via blockade of alpha2-noradrenergic autoreceptor and heteroreceptor and to have common side effects such as sedation, weight gain, and dizziness. We report a case of 50 years old female depressive patient who developed mirtazapine-associated hyperglycemia during treatment with mirtazapine and returned to normal glucose level after stopping the usage of mirtazapine. In patients who receive drugs with the risk of hyperglycemia and diabetes mellitus, we should consider the evaluation for diabetes mellitus and follow it up carefully in the future.
